Registry trials for oligometastatic disease: rational and current status of the E2R OligoCare project
SP-0519
Abstract
Registry trials for oligometastatic disease: rational and current status of the E2R OligoCare project
Authors: Piet Ost(Iridium Network, GZA Ziekenhuizen, Radiation Oncology, Antwerp, Belgium)
Show Affiliations
Hide Affiliations